Genmont Biotech Inc. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$37,785,000 NT$39,947,000
Jan-Apr Revenue NT$126,955,000 NT$139,399,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].